The Hematologist

By The HematologistScience

The Hematologist episodes

March 01, 2021 Clonal Hematopoiesis and Risk of T-MN, With Drs. Amy DeZern & Kelly Bolton
In this podcast, Contributing Editor Dr. Amy DeZern has a conversation with Dr. Kelly Bolton. They discuss Dr. DeZern’s Diffusion article from the March/April 2021 issue of The Hematologist, titled, "Short-term Gain But Long-term Pain? Clonal Hematopoiesis and the Risk of Therapy-related Myeloid Neoplasms After Treatment for Solid Tumors." They discuss the relationship between clonal hematopoiesis and the risk of therapy-related myeloid neoplasms which can help tailor individualized therapy. You can access her Diffusion article online at https://ashpublications.org/thehematologist/article/475183/Short-term-Gain-But-Long-term-Pain-Clonal.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
17 min
February 16, 2021 ASH Advocacy & New Administration Health Care Priorities With Drs. Donald & Holter-Chakrabarty
In this installment of The Hematologist podcast, Chair of the ASH Committee on Government Affairs Dr. Jennifer Holter-Chakrabarty and Chair of the ASH Committee on Practice Dr. Chancellor Donald have a conversation about the new Administration’s health care priorities as well as planned ASH advocacy efforts and initiatives. Learn more by visiting www.hematology.org/advocacy. Find additional ASH resources available to help the hematology community be prepared and proactive during the COVID-19 public health crisis, by visiting www.hematology.org/COVID-19. If you have recommendations for topics to cover in this podcast series, please email us at [email protected].
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
24 min
January 04, 2021 Year's Best: The BELLINI Study, With Drs. Irene Ghobrial and Shaji Kumar
In this podcast, Contributing Editor Dr. Irene Ghobrial has a conversation with Dr. Shaji Kumar. They discuss Dr. Ghobrial’s Year’s Best article from the January/February 2021 issue of The Hematologist, titled, "The BELLINI Study and the Dawn of Precision Medicine in Multiple Myeloma." They discuss a randomized, double-blinded, phase III trial testing the combination of venetoclax or placebo with bortezomib and dexamethasone in relapsed or refractory multiple myeloma. You can access her Year’s Best article online at https://ashpublications.org/thehematologist/article/474709/The-BELLINI-Study-and-the-Dawn-of-Precision.
Conflicts of Interest: Dr. Kumar has received research funding for clinical trials to the institution from Abbvie, Amgen, BMS, Carsgen, Janssen, KITE, Merck, Medimmune, Novartis, Roche-Genentech, Takeda, and Tenebio, and has consulted or participated in advisory boards (with no personal payments) for Abbvie, Amgen, BMS, Janssen, Roche-Genentech, Takeda, and (with personal payment) Oncopeptides, Beigene. Dr. Ghobrial has consulted for GSK (and Advisory Board participation), Sanofi, Janssen, Takeda, Karyopharm, AbbVie, GNS (Ad. Board participation), Cellectar, Medscape, Genentech, Adaptive, BMS, Aptitude (Ad. Board participation), and Curio Science.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
15 min
November 16, 2020 2020 ASH Annual Meeting: A Guide for Trainees, With Drs. Ajay Major and Lachelle Weeks
In this installment of the 2020 ASH Annual Meeting podcast series, Dr. Ajay Major and Dr. Lachelle Dawn Weeks help members of the trainee community navigate the upcoming 62nd ASH Annual Meeting. They provide important information about events and sessions of interest to the trainee community as well as features of the virtual platform that will help trainees stay connected in this new all-virtual environment. To access these resources and find additional information about what to expect, visit www.hematology.org/annual-meeting.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
10 min
November 16, 2020 2020 ASH Annual Meeting: Disparities in Science, With Drs. Laura Michaelis & Chancellor Donald
In this installment of the 2020 ASH Annual Meeting podcast series, Editor-in-Chief Dr. Laura Michaelis has a conversation with Dr. Chancellor Donald. They discuss disparities in science, outcomes, and access to care, as well as planned sessions at this year’s ASH Annual Meeting that will address these topics. To access meeting resources and find additional information about what to expect, visit www.hematology.org/annual-meeting.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
19 min
November 02, 2020 Is Dose-adjusted EPOCH-R Enough for Burkitt Lymphoma? With Drs. Brad Kahl and Mark Roschewski
In this podcast, Contributing Editor Dr. Brad Kahl has a conversation with Dr. Mark Roschewski. They discuss Dr. Kahl's Diffusion article from the November/December 2020 issue of The Hematologist, titled, "Is Dose-adjusted EPOCH-R Enough in Burkitt Lymphoma?" They discuss a study that evaluates the efficacy of the dose-adjusted EPOCH-R regimen in adult patients with Burkitt lymphoma. You can access his Diffusion article online at https://ashpublications.org/thehematologist/article/472152/Is-Dose-adjusted-EPOCH-R-Enough-in-Burkitt.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
14 min
October 15, 2020 Get Involved With ASH Advocacy, With Drs. Chancellor Donald, Alan Rosmarin, & Laura Michaelis
In this installment of The Hematologist podcast and the COVID-19 podcast series, Editor-in-Chief Dr. Laura Michaelis has a conversation with Chair of the ASH Committee on Practice Dr. Chancellor Donald and Chair of the ASH Committee on Government Relations Dr. Alan Rosmarin about ASH advocacy initiatives, how advocacy has changed as a result of the COVID-19 pandemic, and how interested members can get involved in Society advocacy efforts on behalf of the hematology community. Learn more by visiting www.hematology.org/advocacy. Find additional ASH resources available to help the hematology community be prepared and proactive during the COVID-19 public health crisis, by visiting www.hematology.org/COVID-19. If you have recommendations for topics to cover in this podcast series, please email us at [email protected].
While we regularly review and update the links, resources, and FAQs posted on the ASH website to reflect the best information available at a given point in time, the COVID-19 pandemic is a rapidly evolving global health crisis. Please take note of the dates of publication for each podcast.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
21 min
October 13, 2020 COVID-19 Update 15: The Latest ASH Resources, With Drs. Stephanie Lee and Laura Michaelis
In this installment, The Hematologist Editor-in-Chief Dr. Laura Michaelis has a conversation with 2020 ASH President Dr. Stephanie Lee. They discuss the latest ASH COVID-19 resources and updates to existing ones, and how Dr. Lee has been dealing with the pandemic since we last heard from her on the very first episode in this series back in March. Find additional ASH resources available to help the hematology community be prepared and proactive during the COVID-19 public health crisis, by visiting www.hematology.org/COVID-19. If you have recommendations for topics to cover in this podcast series, please email us at [email protected].
While we regularly review and update the links, resources, and FAQs posted on the ASH website to reflect the best information available at a given point in time, the COVID-19 pandemic is a rapidly evolving global health crisis. Please take note of the dates of publication for each podcast.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
15 min
September 30, 2020 COVID-19 Update 14: The Latest on Convalescent Plasma, With Drs. Laura Michaelis and Evan Bloch
In this installment, The Hematologist Editor-in-Chief Dr. Laura Michaelis has a conversation with Dr. Evan Bloch of Johns Hopkins University School of Medicine. They discuss the latest updates on convalescent plasma. Find additional ASH resources available to help the hematology community be prepared and proactive during the COVID-19 public health crisis, by visiting www.hematology.org/COVID-19. If you have recommendations for topics to cover in this podcast series, please email us at [email protected].
While we regularly review and update the links, resources, and FAQs posted on the ASH website to reflect the best information available at a given point in time, the COVID-19 pandemic is a rapidly evolving global health crisis. Please take note of the dates of publication for each podcast.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
20 min
September 01, 2020 Does the Immune System Matter in Treatment for AML? With Drs. Steven Lane & Sergio Rutella
In this podcast, Contributing Editor Dr. Steven Lane has a conversation with Dr. Sergio Rutella. They discuss Dr. Lane's Diffusion article from the September/October 2020 issue of The Hematologist, titled, "Does the Immune System Matter in Treatment for AML?" They discuss the role of the immune system in the treatment of acute myeloid leukemia. You can access his Diffusion article online at https://ashpublications.org/thehematologist/article/463586/Does-the-Immune-System-Matter-in-Treatment-for-AML.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
18 min

About The Hematologist

From the publisher's feed

The Hematologist is the member newsletter of American Society of Hematology (ASH). It is designed for the broad constituency of ASH, all working toward the ultimate goal of conquering blood diseases.…